THE TUBEROUS SCLEROSIS ASSOCIATION — grant history
Latest income
£478k
Grants listed (FY2025)
2
Listed grants total
£67k
Accounts grants total
£44k
listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts
Application guidance — from the funder’s own website
- Deadlines: Deadline Monday 1 December, 13:00 GMT.
- What they don’t fund: There’s some things that we don’t pay for through the TSA Support Fund: Travel costs to attend a TSA event – for this, get in touch as we might be able to offer you a travel bursary Where a statutory authority has a responsibility to pay for the item needed Something you’ve already paid for, booked or ordered Costs associated with debt
What this funder supports
Where grantees operate
- Cardiff
- Throughout England And Wales
What changed: FY2024 → FY2025
| Change | Grantee | FY2024 | FY2025 |
|---|---|---|---|
| new | University of Bristol NHS Foundation Trust | — | £34k |
| new | EPILEPSY RESEARCH INSTITUTE UK | — | £33k |
| not listed | UZ Brussels | £11k | — |
| not listed | University College London | £11k | — |
| not listed | University of Bristol | £11k | — |
| not listed | University of Birmingham | £11k | — |
| not listed | University of Cape Town | £11k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Bristol NHS Foundation Trust | FY2025 | £34k | Randomised Controlled Trial of ACT in TSC |
| Epilepsy Research Institute UK | FY2025 | £33k | Investigating new targets for TSC treatments |
| UZ Brussels | FY2024 | £11k | The TANDem Project |
| University College London | FY2024 | £11k | Investigating new targets for TSC treatments |
| University of Bristol | FY2024 | £11k | Better understanding the accessibility of mental health services for children and young people with TSC / The TANDem Project |
| University of Birmingham | FY2024 | £11k | Exploring Sleep experiences in people with TSC (e-Slept) |
| University of Cape Town | FY2024 | £11k | The TANDem Project / TAND in India / Well-Beans for Caregivers Programme |
| University of Bristol NHS Foundation Trust | FY2023 | £33k | Randomised Controlled Trial of Acceptance and Commitment Therapy in the Tuberous Sclerosis Complex |
| TANDem Consortium | FY2023 | £8k | to fund a number of small seed projects linked to the TANDem project to help build research capacity in TAND. |
| Cardiff University | FY2023 | £5k | Targeting the Ref1/STAT3 axis to treat Tuberous Sclerosis Complex |
| Institute of Medical Genetics, Cardiff | FY2023 | £1k | |
| Cardiff University | FY2023 | £620 | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| Cardiff University | FY2023 | £618 | |
| Research Department of Genetics, University College, London | FY2023 | £513 | |
| University College London | FY2023 | £228 | The TSC1 and TSC2 Variation Databases |
| Erasmus MC, Department of Clinical Genetics | FY2023 | £180 | |
| Institute of Psychiatry Psychology and Neuroscience | FY2023 | £67 | Neurocognitive predictors of neurodevelopmental impairment in infants and toddlers with TSC |
| Cardiff University | FY2023 | £65 | An innovative model system to cell invasion in TSC/LAM to uncover new drug targets and therapies |
| TANDem Consortium | FY2022 | £37k | to fund a number of small seed projects linked to the TANDem project to help build research capacity in TAND. |
| TANDem Consortium | FY2022 | £26k | to fund a number of small seed projects linked to the TANDem project to help build research capacity in TAND. |
| TANDem Consortium | FY2022 | £26k | to fund a number of small seed projects linked to the TANDem project to help build research capacity in TAND. |
| Cardiff University | FY2022 | £26k | An innovative model system to cell invasion in TSC/LAM to uncover new drug targets and therapies |
| Centre for Integrative Physiology, University of Edinburgh | FY2022 | £25k | An innovative model system to cell invasion in TSC/LAM to uncover new drug targets and therapies |
| Cardiff University | FY2022 | £21k | An innovative model system to cell invasion in TSC/LAM to uncover new drug targets and therapies |
| TANDem Consortium | FY2022 | £21k | to fund a number of small seed projects linked to the TANDem project to help build research capacity in TAND. |
| Erasmus MC, Department of Clinical Genetics | FY2022 | £15k | Targeting the Refl/STAT3 axis to treat Tuberous Sclerosis Complex |
| Cardiff University | FY2022 | £10k | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| University of Bristol NHS Foundation Trust | FY2022 | £9k | Randomised Controlled Trial of Acceptance and Commitment Therapy in Tuberous Sclerosis Complex |
| University of Birmingham | FY2022 | £3k | Exploring Sleep experiences in people with tuberous sclerosis complex (e-Slept) |
| Cardiff University | FY2022 | £3k | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| University of Bristol NHS Foundation Trust | FY2022 | £2k | Randomised Controlled Trial of Acceptance and Commitment Therapy in Tuberous Sclerosis Complex |
| Institute of Medical Genetics, Cardiff | FY2022 | £1k | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| Institute of Psychiatry Psychology and Neuroscience | FY2022 | £620 | Neurocognitive predictors of neurodevelopmental impairment in infants and toddlers with TSC |
| Cardiff University | FY2022 | £618 | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| Department of Genetics, University College, London | FY2022 | £618 | The TSCI and TSC2 Variation Databases |
| University of Manchester, Faculty of Life Sciences | FY2022 | £513 | Towards specific Motor Inhibitors capable of rescuing Tuberous Sclerosis Complex loss-of-function |
| Kings College London | FY2022 | £335 | Neurocognitive predictors of neurodevelopmental impairment in infants and toddlers with TSC |
| University College London | FY2022 | £228 | The TSCI and TSC2 Variation Databases |
| Erasmus MC, Department of Clinical Genetics | FY2022 | £226 | Targeting the Refl/STAT3 axis to treat Tuberous Sclerosis Complex |
| Whitehead Institute | FY2022 | £185 | Towards specific Motor Inhibitors capable of rescuing Tuberous Sclerosis Complex loss-of-function |
| University of Bristol NHS Foundation Trust | FY2022 | £183 | Randomised Controlled Trial of Acceptance and Commitment Therapy in the Tuberous Sclerosis Complex |
| Cardiff University | FY2022 | £180 | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| Institute of Psychiatry Psychology and Neuroscience | FY2022 | £67 | Neurocognitive predictors of neurodevelopmental impairment in infants and toddlers with TSC |
| Cardiff University | FY2022 | £65 | Characterising the roles of exosomes in Tuberous Sclerosis Complex |
| Whitehead Institute | FY2021 | £51k | Towards Specific Motor Inhibitors Capable of Rescuing Tuberous Sclerosis Complex Loss-of-function |
| Cardiff University | FY2021 | £33k | Targeting the Refl/STAT3 axis to treat Tuberous Sclerosis Complex |
| Cardiff University | FY2021 | £33k | Characterising the Role of Exosomes in Tuberous Sclerosis |
| Cardiff University | FY2021 | £31k | An innovative model system of cell invasion in TSC/LAM to uncover new drug targets and therapies |
| University of Bristol NHS Foundation Trust | FY2021 | £30k | Randomised Controlled Trial of Acceptance and Commitment Therapy in the Tuberous Sclerosis Complex |
| TANDem Consortium | FY2021 | £26k | to fund a number of small seed projects linked to the TANDem project to help build research capacity in TAND |
| Centre for Integrative Psysiology, University of Edinburgh | FY2021 | £16k | Neurocognitive predictors of neurodevelopmental impairment in infants and toddlers with TSC |
| University of Birmingham | FY2021 | £14k | Understanding the limits of everolimus and rapamycin |
| Institute of Psychiatry, Kings College London | FY2021 | £14k | Designing a Protocol to Measure the Development Trajectory of Infants with Tuberous Sclerosis |